Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 2
2007 2
2009 1
2011 3
2012 2
2013 5
2014 6
2015 6
2016 7
2017 5
2018 6
2019 13
2020 6
2021 8
2022 7
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
A Deep Learning-Based Assessment Pipeline for Intraepithelial and Stromal Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Carcinoma.
Hamada K, Murakami R, Ueda A, Kashima Y, Miyagawa C, Taki M, Yamanoi K, Yamaguchi K, Hamanishi J, Minamiguchi S, Matsumura N, Mandai M. Hamada K, et al. Among authors: murakami r. Am J Pathol. 2024 Mar 25:S0002-9440(24)00110-X. doi: 10.1016/j.ajpath.2024.02.016. Online ahead of print. Am J Pathol. 2024. PMID: 38537936
Peritoneal dissemination of high-grade serous ovarian cancer: pivotal roles of chromosomal instability and epigenetic dynamics.
Konishi I, Abiko K, Hayashi T, Yamanoi K, Murakami R, Yamaguchi K, Hamanishi J, Baba T, Matsumura N, Mandai M; Kyoto Study Group for Ovarian Cancer Research. Konishi I, et al. Among authors: murakami r. J Gynecol Oncol. 2022 Sep;33(5):e83. doi: 10.3802/jgo.2022.33.e83. J Gynecol Oncol. 2022. PMID: 36032027 Free PMC article. Review.
Author Correction: Comprehensive genomics in androgen receptor-dependent castration-resistant prostate cancer identifies an adaptation pathway mediated by opioid receptor kappa 1.
Makino Y, Kamiyama Y, Brown JB, Tanaka T, Murakami R, Teramoto Y, Goto T, Akamatsu S, Terada N, Inoue T, Kodama T, Ogawa O, Kobayashi T. Makino Y, et al. Among authors: murakami r. Commun Biol. 2022 Jul 19;5(1):718. doi: 10.1038/s42003-022-03707-z. Commun Biol. 2022. PMID: 35854103 Free PMC article. No abstract available.
Efficacy of pazopanib in FGFR1-amplified uterine carcinosarcoma: A case report.
Sawayama S, Murakami R, Aki M, Kawaguchi Y, Takao Y, Nonogaki H, Goto T, Yamauchi C. Sawayama S, et al. Among authors: murakami r. Gynecol Oncol Rep. 2022 May 2;41:100993. doi: 10.1016/j.gore.2022.100993. eCollection 2022 Jun. Gynecol Oncol Rep. 2022. PMID: 35586703 Free PMC article.
Comprehensive genomics in androgen receptor-dependent castration-resistant prostate cancer identifies an adaptation pathway mediated by opioid receptor kappa 1.
Makino Y, Kamiyama Y, Brown JB, Tanaka T, Murakami R, Teramoto Y, Goto T, Akamatsu S, Terada N, Inoue T, Kodama T, Ogawa O, Kobayashi T. Makino Y, et al. Among authors: murakami r. Commun Biol. 2022 Apr 1;5(1):299. doi: 10.1038/s42003-022-03227-w. Commun Biol. 2022. PMID: 35365763 Free PMC article.
Immunosuppressive tumor microenvironment in uterine serous carcinoma via CCL7 signal with myeloid-derived suppressor cells.
Mise Y, Hamanishi J, Daikoku T, Takamatsu S, Miyamoto T, Taki M, Yamanoi K, Yamaguchi K, Ukita M, Horikawa N, Abiko K, Murakami R, Furutake Y, Hosoe Y, Terakawa J, Kagabu M, Sugai T, Osakabe M, Fujiwara H, Matsumura N, Mandai M, Baba T. Mise Y, et al. Among authors: murakami r. Carcinogenesis. 2022 Aug 30;43(7):647-658. doi: 10.1093/carcin/bgac032. Carcinogenesis. 2022. PMID: 35353883
74 results